Herbal-Review.com

Independent honest reviews of most effective natural herbal supplements

Erbitux adds 5 weeks to lung cancer survival (Reuters)

by @ 6:24 pm on May 31, 2008.

Reuters - Lung cancer patients treated in a large
clinical trial with ImClone Systems Inc’s Erbitux and
chemotherapy lived about five weeks longer than patients
treated with chemotherapy alone, according to study results
released on Saturday.

Mature Cams Free Nude Chat Free Asian Live Sex Web Cams Naked Live Sex Chat Rezidentiale Anunturi Imobiliare BBW Porn Movies Auto

[link]

08/15/2008: Presenting a Nutritionally Dense Smoothie Recipe

07/02/2008: FDA panel urges more testing for diabetes drugs (AP)

08/03/2008: Abbott faces more litigation over AIDS drug (AP)

08/05/2008: Physical activity low among immigrant children (Reuters)

07/22/2008: Nursing Homes Unprepared for Pandemic Flu Fallout (HealthDay)

The URI to TrackBack this entry is: http://herbal-review.com/2008/05/31/erbitux-adds-5-weeks-to-lung-cancer-survival-reuters/trackback/

One Response to “Erbitux adds 5 weeks to lung cancer survival (Reuters)”

Erbitux adds 5 weeks to lung cancer survival (Reuters) Says:
May 31st, 2008 at 6:57 pm
[…] Tim wrote an interesting post today onHere’s a quick excerptReuters - Lung cancer patients treated in a large clinical trial with ImClone Systems Inc’s Erbitux and chemotherapy lived about five weeks longer than patients treated with chemotherapy alone, according to study results … […]